EUVIMEDEUVIMED entdecken
Fallbericht

A case of persistent, confluent maculopapular erythema following a COVID ‐19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis

Hozumi Sano, Misaki Kase, Yukiko Aoyama, Shigetoshi Sano iD

The Journal of Dermatology · 2023

DOI: 10.1111/1346-8138.16816 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Hozumi Sano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan. Hauptthemen laut MEDLINE: Eccrine Glands, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, we report an 86‐year‐old Japanese woman presenting with confluent maculopapular erythema, which developed following the second dose of COVID‐19 Messenger RNA (mRNA) vaccine (BNT162b2). Her skin lesions spread over time and persisted for more than 3 months. Surprisingly, immunohistochemical staining of the lesion 100 days after the disease onset revealed the COVID‐19 spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis. As she had no episode of COVID‐19 infection, it is highly likely that the spike protein was derived from the mRNA vaccine and it might be the cause of the development and persistence of her skin lesions. Her symptoms were prolonged and intractable until oral prednisolone was given.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eccrine GlandsCOVID-19HumansFemaleAged, 80 and overEndothelial CellsBNT162 VaccineSpike Glycoprotein, CoronavirusVaccinationCOVID-19 VaccinesRNA, MessengerErythemaDermis

Stichwörter der Autor:innen

BNT162b2COVID-19 mRNA vaccineconfluent maculopapular erythemacutaneous adverse reactionspike protein

Substanzen

spike protein, SARS-CoV-2BNT162 VaccineSpike Glycoprotein, CoronavirusCOVID-19 VaccinesRNA, Messenger

Autor:innen und Institutionen

  • Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.

ORCID-Profile: Shigetoshi Sano

Zitieren

APA

Sano, H., Kase, M., Aoyama, Y., & Sano, S. (2023). A case of persistent, confluent maculopapular erythema following a COVID ‐19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16816

Vancouver

Sano H, Kase M, Aoyama Y, Sano S. A case of persistent, confluent maculopapular erythema following a COVID ‐19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16816

BibTeX
@article{Sano2023,
  author = {Sano, Hozumi and Kase, Misaki and Aoyama, Yukiko and Sano, Shigetoshi},
  title = {A case of persistent, confluent maculopapular erythema following a COVID ‐19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis},
  journal = {The Journal of Dermatology},
  year = {2023},
  doi = {10.1111/1346-8138.16816}
}
Kostenlos starten →